David L Friedman

Title: David L Friedman: Innovator in Myotonic Muscular Dystrophy Diagnosis

Introduction

David L Friedman is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of genetics, particularly in the diagnosis of myotonic muscular dystrophy. His innovative work has led to advancements in understanding and detecting this genetic disorder.

Latest Patents

David L Friedman holds a patent for the "Diagnosis of myotonic muscular dystrophy." This invention includes a DNA clone from the myotonic muscular dystrophy gene and a cosmid probe to the myotonic dystrophy site. The methods described in the patent involve detecting myotonic muscular dystrophy using restriction fragment length polymorphism (RFLP). The process includes digesting DNA from an individual with a restriction endonuclease and detecting the resulting fragments through hybridization to specific probes and southern blot analysis. Additionally, the gene can be measured by assessing mRNA levels or protein amounts using antibodies. The patent also outlines methods for detecting the gene defect using fluorescence in situ hybridization or pulsed field gel electrophoresis.

Career Highlights

David L Friedman is affiliated with Baylor College of Medicine, where he continues to contribute to research and innovation in genetics. His work has been instrumental in advancing the understanding of myotonic muscular dystrophy and improving diagnostic methods.

Collaborations

Some of his notable coworkers include C Thomas Caskey and Antonio Pizzuti. Their collaborative efforts have further enhanced the research and development of diagnostic techniques in the field.

Conclusion

David L Friedman is a pioneering inventor whose work in the diagnosis of myotonic muscular dystrophy has made a significant impact in the medical field. His innovative approaches and dedication to research continue to influence the understanding of genetic disorders.